Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009
Published online before print March 5, 2009, doi: 10.1161/CIRCRESAHA.108.188292
A more recent version of this article appeared on April 10, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
104/7/905    most recent
CIRCRESAHA.108.188292v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, W.
Right arrow Articles by Wang, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, W.
Right arrow Articles by Wang, X.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Remodeling
Right arrow Cell signalling/signal transduction
Right arrow Genetically altered mice
Right arrow Hypertrophy

Submitted on September 26, 2008
Revised on February 19, 2009
Accepted on February 24, 2009

Cardiac-Specific Deletion of Mkk4 Reveals Its Role in Pathological Hypertrophic Remodeling but Not in Physiological Cardiac Growth

Wei Liu ; Min Zi ; Jiawei Jin ; Sukhpal Prehar ; Delvac Oceandy ; Tomomi E. Kimura ; Ming Lei ; Ludwig Neyses ; Arthur H. Weston ; Elizabeth J. Cartwright ; and Xin Wang *

From the Faculty of Medical and Human Sciences (W.L., M.Z., S.P., D.O., M.L., L.N., E.J.C.) and Faculty of Life Sciences (J.J., T.E.K., A.H.W., X.W.), University of Manchester, United Kingdom.

* To whom correspondence should be addressed. E-mail: xin.wang{at}manchester.ac.uk.

Mitogen-activated protein kinase kinase (MKK)4 is a critical member of the mitogen-activated protein kinase family. It is able to activate the c-Jun NH2-terminal protein kinase (JNK) and p38 mitogen-activated protein kinase in response to environmental stresses. JNK and p38 are strongly implicated in pathological cardiac hypertrophy and heart failure; however, the regulatory mechanism whereby the upstream kinase MKK4 activates these signaling cascades in the heart is unknown. To elucidate the biological function of MKK4, we generated mice with a cardiac myocyte-specific deletion of mkk4 (MKK4cko mice). In response to pressure overload or chronic {beta}-adrenergic stimulation, downregulated NFAT (nuclear factor of activated T-cell) transcriptional activity associated with exacerbated cardiac hypertrophy and the appearance of apoptotic cardiomyocytes were observed in MKK4cko mice. However, when subjected to swimming exercise, MKK4cko mice displayed a similar level of physiological cardiac hypertrophy compared to controls (MKK4f/f). In addition, we also discovered that MKK4 expression was significantly reduced in heart failure patients. In conclusion, this study demonstrates for the first time that MKK4 is a key mediator which prevents the transition from an adaptive response to maladaptive cardiac hypertrophy likely involving the regulation of the NFAT signaling pathway.


Key words: cardiac hypertrophy • signal transduction • genetically modified mice




This article has been cited by other articles:


Home page
CirculationHome page
D. Oceandy, A. Pickard, S. Prehar, M. Zi, T. M.A. Mohamed, P. J. Stanley, F. Baudoin-Stanley, R. Nadif, S. Tommasi, G. P. Pfeifer, et al.
Tumor Suppressor Ras-Association Domain Family 1 Isoform A Is a Novel Regulator of Cardiac Hypertrophy
Circulation, August 18, 2009; 120(7): 607 - 616.
[Abstract] [Full Text] [PDF]